These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Which drug for peptic ulcer?]. Hameeteman W; Tytgat GN Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1673-6. PubMed ID: 2864643 [No Abstract] [Full Text] [Related]
3. [Acid anti-secretion therapy in gastric and duodenal ulcer]. Lattanzi A Clin Ter; 1981 Oct; 99(2):187-205. PubMed ID: 6119184 [No Abstract] [Full Text] [Related]
4. Another look at peptic ulcer. Piper DW; Barr GD Aust Fam Physician; 1981 Aug; 10(8):636-40. PubMed ID: 6117272 [No Abstract] [Full Text] [Related]
5. Drugs in the treatment of gastric and duodenal ulcer. Langman MJ Drugs; 1977 Aug; 14(2):105-15. PubMed ID: 19225 [No Abstract] [Full Text] [Related]
6. [Clinical problems in the diagnosis and treatment of duodenal ulcer and stomach ulcer. A report]. Andersen D; Rune SJ; Søltoft J; Wulff HR Ugeskr Laeger; 1984 Apr; 146(14):1055-7. PubMed ID: 6145240 [No Abstract] [Full Text] [Related]
7. [Current directions in the treatment of gastric and duodenal ulcers]. Fellus R Dakar Med; 1988; 33(1-4):42-4. PubMed ID: 2908566 [No Abstract] [Full Text] [Related]
8. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists]. Hentschel E Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397 [No Abstract] [Full Text] [Related]
9. [Acid secretory rebound after gastric antisecretory treatment. Above all, a problem for the physiologists!]. Vallot T; Mignon M Gastroenterol Clin Biol; 1994; 18(8-9):677-9. PubMed ID: 7875433 [No Abstract] [Full Text] [Related]
10. [Clinical importance of antagonists of histamine H2 receptors in gastroenterology]. Carella G Clin Ter; 1984 Mar; 108(6):525-9. PubMed ID: 6144411 [No Abstract] [Full Text] [Related]
11. Medical and surgical treatment of chronic gastric ulcer. Kelly KA; Malagelada JR Clin Gastroenterol; 1984 May; 13(2):621-34. PubMed ID: 6146418 [No Abstract] [Full Text] [Related]
12. [New antisecretory drugs in the treatment of ulcer]. Sheptulin AA Klin Med (Mosk); 1994; 72(1):12-5. PubMed ID: 7910870 [No Abstract] [Full Text] [Related]
13. [Pharmacotherapy of non-associated with Helicobacter pylori ulcer]. Grinevich VB; Uspenskiĭ IuP; Shabanova GZh; Sablin OA; Shcherbina NN Klin Med (Mosk); 2002; 80(10):44-6. PubMed ID: 12471838 [TBL] [Abstract][Full Text] [Related]
14. [Peptic ulcer: changes in the surgical approach after the introduction of H2-antagonists in clinical practice]. Rimassa PL; Marino G; Quartapelle V; D'Asta F; Maggiolo G; Manno A; Piffero D; Schiappacasse E Minerva Chir; 1987 Oct; 42(19):1499-502. PubMed ID: 2891087 [No Abstract] [Full Text] [Related]
15. [Influence of H2-blocking drugs on the surgical therapy of peptic ulcer]. Procacciante F; Pronio A; Perri S; Di Nardo A; Montesani C; Citone G; Catani M; Ribotta G Minerva Chir; 1987 Oct; 42(19):1491-4. PubMed ID: 2891085 [No Abstract] [Full Text] [Related]
17. [Pharmacology and clinical effects of acid determination in ulcer hemorrhage]. Schepp W Bildgebung; 1993 Apr; 60 Suppl 1():41-4. PubMed ID: 8104063 [No Abstract] [Full Text] [Related]
18. [Influence of anti-H2-receptors on the surgery of peptic ulcer]. Cavallesco NG; Morsiani E; Lupi L; Dalla Valle GB; Fogli L; Belcastro S; Pampolini M; Pollice S; Santini A Minerva Chir; 1987 Oct; 42(19):1495-7. PubMed ID: 2891086 [No Abstract] [Full Text] [Related]